Elsevier

The Spine Journal

Volume 19, Issue 7, July 2019, Pages 1162-1169
The Spine Journal

Clinical Study
Cost-effectiveness of microdiscectomy versus endoscopic discectomy for lumbar disc herniation

https://doi.org/10.1016/j.spinee.2019.02.003Get rights and content

ABSTRACT

BACKGROUND CONTEXT

Microdiscectomy is a standard technique for the surgical treatment of lumbar disc herniation (LDH). Endoscopic discectomy (ED) is another surgical option that has become popular owing to reports of shorter hospitalization and earlier return to work. No study has evaluated health care costs associated with lumbar discectomy techniques and compared cost-effectiveness.

PURPOSE

To assess the cost-effectiveness of four surgical techniques for LDH: microdiscectomy (MD), transforaminal endoscopic lumbar discectomy (TELD), interlaminar endoscopic lumbar discectomy (IELD), and unilateral biportal endoscopic discectomy (UBED).

STUDY DESIGN AND SETTING

Retrospective analysis.

PATIENT SAMPLE

Patients who underwent either MD or ED for primary LDH with 1-year follow-up between the ages of 20 and 60 years old.

OUTCOME MEASURES

Incremental cost-effectiveness ratio (ICER).

METHODS

Five hundred sixty-five patients aged 20–60 years who underwent treatment using one of the four surgical techniques with at least 1-year follow-up were reviewed. Health care costs were defined as the sum of direct and indirect costs. The former included the covered and uncovered costs of the National Health Insurance from operation to 1-year follow-up; indirect costs included costs incurred by work loss. Direct and indirect costs were evaluated separately. ICER was determined using cost/quality-adjusted life year (QALY). Health care costs and ICER were compared statistically among the four surgical groups. Cost-effectiveness was compared statistically between MD and ED.

RESULTS

One hundred fifty-seven patients who underwent TELD, 132 for IELD, 140 for UBED, and 136 for MD were enrolled. The direct costs of TELD, IELD, UBED, and MD were $3,452.2±1,211.5, $3,907.3±895.3, $4,049.2±1,134.6, and $4,302.1±1,028.9, respectively (p<.01). The indirect costs of TELD, IELD, UBED, and MD were $574.5±495.9, $587.8±488.3, $647.4±455.6, and $759.7±491.7, respectively (p<.01). The 1-year QALY gains were 0.208 for TELD, 0.211 for IELD, 0.194 for UBED, and 0.186 for MD. ICER (costs/QALY) was the highest for MD ($34,840.4±25,477.9, p<.01). Compared with MD, ED saved an additional net of $8,064 per QALY (p<.01). There was no significant difference in the ICERs among the three endoscopic techniques.

CONCLUSIONS

ED was more cost-effective compared with MD at 1-year follow up.

Introduction

Microdiscectomy is a standard technique for the surgical treatment of lumbar disc herniation. Since 1980 [1], different types of endoscopic discectomy, such as transforaminal endoscopic lumbar discectomy (TELD) and interlaminar endoscopic lumbar discectomy (IELD), have been introduced and evolved [1]. Unilateral biportal endoscopic discectomy (UBED) has been recently introduced using a two portal system, with one portal for the endoscope and another for the entry of surgical instruments, similar to joint arthroscopy [2], [3]. This technique, although not a full-endoscopic discectomy, combines the advantages of standard open and endoscopic spinal surgery. Endoscopic discectomy has become more popular with surgeons and patients as it is associated with lesser postoperative pain, shorter hospital stays and earlier returns to work [4], [5], [6]. No study has been conducted to evaluate health care costs associated with lumbar discectomy techniques and compare cost-effectiveness. The purpose of this study was to compare total hospital costs among microdiscectomy and three different endoscopic techniques and to analyze cost-effectiveness using the incremental cost-effectiveness ratio (ICER).

Section snippets

Methods

After obtaining approval for this study from our Institutional Review Board (2017-W06), written informed consent was obtained from patients. Consecutively, 598 patients aged between 20 and 60 years underwent discectomy from January 2016 to December 2016. All patients presented with sciatica and back pain that did not improve with conservative treatment for a minimum of 6 weeks. They underwent plain radiography, magnetic resonance imaging (MRI), and computed tomography (CT). Patients who had an

Patient population

A total of 726 consecutive patients underwent lumbar discectomy during the study period, and 565 (94.5%) of the 598 patients were enrolled in the study considering age. Thirty-three patients were lost to follow-up. A total of 157 patients for TELD, 132 for IELD, 140 for UBED, and 136 for MD were finally included. The mean ages (years) were 45.5±14.1 for patients who underwent TELD, 49.0±13.7 for patients who underwent IELD, 49.1±14.8 for patients who underwent UBED, and 47.9±14.1 for patients

Discussion

In the United States, 500,000 lumbar discectomy surgeries have been performed annually [12]. The total costs of low back pain in the United States exceed $100 billion per year [13]. According to the Spine Patient Outcomes Research Trial for lumbar disc herniation, although surgery costs ($27,273) were higher than medical interventional costs ($13,135), cost per QALY of surgery ($34,355) was lower than that of medical interventional treatment ($69,403) [14]. Surgery contributes tenfold to

Conclusions

Although both MD and ED are cost-effective surgical treatments at least in the authors’ country, our data demonstrate that ED is more cost-effective compared to MD. There is no difference in cost-effectiveness among TELD, IELD, and UBED.

References (29)

  • H.M. Soliman

    Irrigation endoscopic decompressive laminotomy. A new endoscopic approach for spinal stenosis decompression

    Spine J

    (2015)
  • S.L. Parker et al.

    Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis: comparative effectiveness and cost-utility analysis

    World Neurosurg

    (2014)
  • Kambin P., Sampson S. Posterolateral percutaneous suction-excision of herniated lumbar intervertebral discs. Report of...
  • J. Hwa Eum et al.

    Percutaneous biportal endoscopic decompression for lumbar spinal stenosis: a technical note and preliminary clinical results

    J Neurosurg Spine

    (2016)
  • K.C. Choi et al.

    Percutaneous endoscopic lumbar discectomy as an alternative to open lumbar microdiscectomy for large lumbar disc herniation

    Pain Physician

    (2016)
  • X. Liu et al.

    Comparison of percutaneous endoscopic transforaminal discectomy, microendoscopic discectomy, and microdiscectomy for symptomatic lumbar disc herniation: minimum 2-year follow-up results

    J Neurosurg Spine

    (2018)
  • S. Ruetten et al.

    Full-endoscopic interlaminar and transforaminal lumbar discectomy versus conventional microsurgical technique: a prospective, randomized, controlled study

    Spine (Phila Pa 1976)

    (2008)
  • G. Choi et al.

    Percutaneous endoscopic interlaminar discectomy for intracanalicular disc herniations at L5-S1 using a rigid working channel endoscope

    Neurosurgery

    (2006)
  • K.C. Choi et al.

    Unsuccessful percutaneous endoscopic lumbar discectomy: a single-center experience of 10,228 cases

    Neurosurgery

    (2015)
  • K.C. Choi et al.

    Comparison of surgical invasiveness between microdiscectomy and 3 different endoscopic discectomy techniques for lumbar disc herniation

    World Neurosurg

    (2018)
  • S. Ruetten et al.

    A new full-endoscopic technique for the interlaminar operation of lumbar disc herniations using 6-mm endoscopes: prospective 2-year results of 331 patients

    Minim Invasive Neurosurg

    (2006)
  • D.H. Heo et al.

    Can Percutaneous biportal endoscopic surgery achieve enough canal decompression for degenerative lumbar stenosis? Prospective case-control study

    World Neurosurg

    (2018)
  • D.T. Gray et al.

    Population-based trends in volumes and rates of ambulatory lumbar spine surgery

    Spine (Phila Pa 1976)

    (2006)
  • J.N. Katz

    Lumbar disc disorders and low-back pain: socioeconomic factors and consequences

    J Bone Joint Surg Am

    (2006)
  • Cited by (0)

    FDA device/drug status: Not applicable.

    Author disclosures: KCC: Nothing to disclose. HKS: Nothing to disclose. JSK: Stock Owership: INNOVASIVE, MEDRICS; Consulting: RIWO Spine, Elliquence; Scientific Advisory Board/Other Office: INNOVASIVE. KHC: Nothing to disclose. DCL: Nothing to disclose. ERK: Nothing to disclose. MJK: Nothing to disclose. CKP: Nothing to disclose.

    There were no external funding sources.

    View full text